{"symbol":"ABT","fiscalQuarter":"Q2-2011","reportDate":"2011-07-20","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2011","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Down 0.93%","keyNumbers":[{"metric":"EPS","actual":"$1.12","expected":"N/A","surprise":"+0.63%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an EPS that exceeded expectations, but the stock reacted negatively, declining by 0.93%. The lack of revenue data and management commentary may have contributed to investor uncertainty. Overall, the earnings report reflects mixed signals for the company moving forward.","metaDescription":"Abbott Laboratories (ABT) Q2 2011 earnings: EPS beat by 0.63%. Stock down 0.93%. Full breakdown."}}